Literature DB >> 24358169

Soluble β-amyloid Precursor Protein Alpha binds to p75 neurotrophin receptor to promote neurite outgrowth.

Noriko Hasebe1, Yuki Fujita2, Masaki Ueno3, Kazuhiro Yoshimura4, Yuji Fujino5, Toshihide Yamashita2.   

Abstract

BACKGROUND: The cleavage of β-amyloid precursor protein (APP) generates multiple proteins: Soluble β-amyloid Precursor Protein Alpha (sAPPα), sAPPβ, and amyloid β (Aβ). Previous studies have shown that sAPPα and sAPPβ possess neurotrophic properties, whereas Aβ is neurotoxic. However, the underlying mechanism of the opposing effects of APP fragments remains poorly understood. In this study, we have investigated the mechanism of sAPPα-mediated neurotrophic effects. sAPPα and sAPPβ interact with p75 neurotrophin receptor (p75(NTR)), and sAPPα promotes neurite outgrowth. METHODS AND
FINDINGS: First, we investigated whether APP fragments interact with p75(NTR), because full-length APP and Aβ have been shown to interact with p75(NTR) in vitro. Both sAPPα and sAPPβ were co-immunoprecipitated with p75(NTR) and co-localized with p75(NTR) on COS-7 cells. The binding affinity of sAPPα and sAPPβ for p75(NTR) was confirmed by enzyme-linked immunosorbent assay (ELISA). Next, we investigated the effect of sAPPα on neurite outgrowth in mouse cortical neurons. Neurite outgrowth was promoted by sAPPα, but sAPPα was uneffective in a knockdown of p75(NTR).
CONCLUSION: We conclude that p75(NTR) is the receptor for sAPPα to mediate neurotrophic effects.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24358169      PMCID: PMC3864954          DOI: 10.1371/journal.pone.0082321

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


Introduction

APP, a single transmembrane protein with a long N-terminal extracellular domain and a short cytoplasmic domain, can be processed by two distinct pathways to generate multiple cleaved products [1]. In the primary pathway, α-secretase catalyzes the cleavage of APP to generate a soluble peptide, sAPPα, which includes Aβ sequence, thereby preventing Aβ generation. In the alternative pathway, β-secretase cleaves APP to generate an alternate soluble peptide, sAPPβ, followed by γ-secretase to generate Aβ. The start of APP expression occurs when neurons initiate differentiation at embryonic day (E) 9.5 in the mouse brain [2]. In addition, APP cleavage occurs at the embryonic stage [3]–[6] as well as injured brain tissue [7]–[9]. These observations suggest that APP fragments may have multiple roles in normal brain development and CNS injury. Indeed, it has been shown that sAPPα possesses neurotrophic effects; for example, it promotes neurite outgrowth in vitro [10] and protects neural tissue after brain injury [8], [11]–[13]. However, the underlying mechanism of its neurotrophic effect remains largely unknown. p75NTR mediates a diverse set of functions, including axonal elongation, neuronal survival, and modulation of synaptic transmission [14]. Furthermore, p75NTR can transmit both positive and negative signals for neuronal action. For example, p75NTR mediates axonal elongation through binding to neurotrophins, whereas it is also involved in axon growth inhibition through its interactions with the Nogo receptor (NgR) and LINGO co-receptors [14], [15]. Regarding APP, p75NTR has been reported to associate with both full-length APP and Aβ[16]–[18]. Indeed, Aβ induces cell death via p75NTR in various types of cells, including neurons [19]. This neurotoxic effect occurs through c-Jun kinase (JNK) and c-Jun [20]–[22]. A recent report further demonstrated that the N-terminal fragment of APP (N-APP) interacts with p75NTR [18]. In this study, we assessed whether sAPPα and sAPPβ will also associate with p75NTR. We show that sAPPα and sAPPβ bind to p75NTR, and that sAPPα binding stimulates neurite outgrowth. These results indicate that p75NTR is the receptor for sAPPα to mediate neurotrophic effects.

Materials and Methods

Mice

All experiments were conducted in accordance with the Osaka University Medical School Guide for the Care and Use of Laboratory Animals, and were approved by the institutional committee of Osaka University (Permit Number: 24-067-005). C57BL/6J mice were purchased from Kiwa Animal Farm (Wakayama, Japan).

Plasmid constructs and small interfering RNA (siRNA)

Mouse sAPPα cDNA was generated by polymerase chain reaction (PCR) using primers constructed from APP valiant 2 (accession No. NM_007471) from a postnatal day (P) 4 mouse spinal cord cDNA library. The cDNA of sAPPα was inserted into a pMD20-T vector (TaKara, Shiga, Japan), and then subcloned into a pcDNA5/FRT vector (Invitrogen, Carlsbad, CA, USA). Amino-terminally Hemagglutinin (HA)-tagged full-length human p75NTR was subcloned into the pcDNA3 vector (Invitrogen) [23]. Mouse p75NTR siRNA was designed as described previously [24]. Scrambled siRNA was used as a negative control.

ELISA

ELISA was performed using 96-well microplates (Thermo Fisher Scientific, Waltham, MA, USA) coated with 1% bovine serum albumin (BSA)/phosphate-buffered saline (PBS). Recombinant sAPPα (S9564, Sigma, St. Louis, MO, USA), sAPPβ (SIG-39938, Covance, Princeton, NJ, USA), or C-sAPPα (sAPPα 304–612; S8065, Sigma)–all at 12.2 nM final concentration in a final volume of 50 µL/well–was plated and incubated at 4°C overnight. After washing with PBS recombinant p75NTR extracellular domain fused to human Fc (p75NTR ECD-Fc) chimera protein (1157-NR, R&D Systems, Minneapolis, MN, USA) or Fc-tagged IgG (IgG-Fc) chimera protein (110-HG, R&D Systems) as a control was added to the plate at the indicated concentrations, and incubated for 2 h at room temperature. After incubation, the plate was washed, and goat anti-human IgG-Fc antibody (1∶1000; 55071, Cappel Costa Mesa, CA, USA) was added. Horseradish peroxidase (HRP)-conjugated anti-goat IgG antibody (1∶1000; sc-2020, Santa Cruz, Santa Cruz, CA, USA), substrate reagent, and stop solution (R&D Systems) were used to detect protein binding. Absorbance was measured at 450 nm.

Pull-down assay

His-tagged sAPPα, sAPPβ, or C-sAPPα, and Ni-agarose were incubated in binding buffer (HBSS with 0.2% BSA, 0.1% NaN3, 5 mM CaCl2, 1 mM MgCl2, 20 mM HEPES, pH 7.0) at 4°C for 1 h. Human p75NTR ECD-Fc (1157-NR, R&D Systems) or human IgG-Fc (110-HG, R&D Systems) was added to the solution, and it was incubated at 4°C overnight. Beads were washed five times with the binding buffer. Bound complexes were eluted from beads with SDS loading buffer, and subjected to sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE, 7.5% gel), followed by western blotting with anti-sAPPα antibody (1∶50; 11088, IBL, Fujioka, Japan), anti-human p75 ECD antibody (1∶1000; AB1554, Millipore, Billerica, MA, USA) and anti-human IgG-Fc antibody (1∶1000), or anti-sAPPβ antibody (1∶500; SIG-39138, Covance).

In situ binding of APP fragments to COS-7 cells

COS-7 cells derived from kidney fibroblast cells of monkey were cultured and maintained in Dulbecco's modified Eagle's medium (DMEM) containing 10% fetal bovine serum (FBS). The cells were plated on 3.5-cm dishes coated with poly-l-lysine (PLL) at a density of 4×105 cells/mL 24 h before transfection. The cells were transfected with pcDNA3 or pcDNA3-p75NTR-HA by Lipofectamine 2000 (Invitrogen) according to the manufacturer's instructions. At 40 h after transfection, the cells were fixed in 4% paraformaldehyde (PFA). Non-specific binding sites were blocked in 5% BSA without detergent for 1 h. The cells were incubated with 1.22 nM sAPPα, sAPPβ, or C-sAPPα at 4°C overnight. The binding of sAPPα, sAPPβ, or C-sAPPα to p75NTR was detected by immunostaining with monoclonal anti-sAPPα antibody (3∶1000) or polyclonal anti-sAPPβ antibody (1∶500), and polyclonal anti-p75NTR antibody (1∶1000) with counterstaining by 4′,6′-diamidino-2-phenylindole (DAPI).

Neurite outgrowth assay

Primary dissociated cultures of cortical neurons were prepared from E16 C57BL/6J mice by using a previously described protocol [25]. Briefly, cortices were dissected and removed, minced into small pieces on ice, and then collected in ice-cold PBS. The cells were then incubated with 0.25% trypsin (Gibco/Invitrogen, Paisley, UK) and 500 µg/mL DNase1 (Sigma) at 37°C for 15 min. Dissociated neurons were plated on 4.2-cm2 2-well plastic wells coated with PLL at a density of 0.25×105 neurons/dish in DMEM/Nutrient Mixture F-12 (DMEM/F12) containing B27 supplement (17504-044, Gibco) and penicillin/streptomycin (15140-122, Gibco). The neurons were incubated in the presence of human IgG-Fc or sAPPα at the indicated concentrations (1.22, 2.44, or 4.88 nM) and/or 200 nM KT5720 (420320, Calbiochem, San Diego, CA, USA) for 24 h. The neurons were then fixed in 4% PFA, and immunostained with polyclonal anti-TuJ1 antibody (1∶1000; PRB-435P, Covance). The lengths of the longest neurites were measured by ImageJ software (National Institutes of Health, Bethesda, MD, USA). Cells with neurites shorter than the diameter of its soma were excluded from the analysis.

Nucleofection

Cortical neurons were washed and resuspended in Mouse Neuron Nucleofector Solution (Lonza, Basel, Switzerland) at a final concentration of 5×106 neurons per 100 µL. The cell-nucleofector solution complex (100 µL) and the p75NTR siRNA or control scrambled siRNA (500 pmol) were then gently mixed and transferred into a cuvette, followed by nucleofection using the nucleofector program O-05. Immediately after electroporation, the cells were mixed with 500 µL of pre-warmed DMEM/F12 containing 10% FBS, followed by transference of the cell suspension into 3.5-cm dishes coated with PLL. After 2 h-incubation, the medium was changed to DMEM/F12 containing B27 supplement and penicillin/streptomycin. After 3 days when the expression of p75NTR was reduced by siRNA, neurons were replated on 3.5-cm dishes coated with PLL at a density of 0.5×105 neurons/dish in DMEM/F12 containing 10% FBS. After another 2-h incubation, the medium was changed to DMEM/F12 containing B27 supplement, penicillin/streptomycin and 1.22 nM sAPPα or PBS control. The neurons were incubated for 24 h, fixed in 4% PFA and immunostained with polyclonal anti-TuJ1 antibody (1∶1000). The lengths of the longest neurites were measured by the ImageJ software.

Co-culture of cortical neurons with Chinese hamster ovary (CHO) cells

CHO cells were plated on 3.5-cm dishes coated with PLL at a density of 3×105 cells/dish in DMEM/F12 containing 10% FBS 24 h before transfection. pcDNA5/FRT vector or sAPPα inserted pcDNA5/FRT vector were transfected into CHO cells. The expression of sAPPα protein was confirmed as described below. At 12 h after transfection, the medium was changed to new DMEM/F12 containing 10% FBS. At 15 h after transfection, cortical neurons (0.5×105 cells/dish) were plated on CHO cells. After another 2 h the medium was changed to DMEM/F12 containing B27 supplement and penicillin/streptomycin. At 40 h after co-culture, CHO cells and neurons were fixed and immunostained with polyclonal anti Tuj1-antibody (1∶1000) and monoclonal anti sAPPα-antibody (3∶1000). The lengths of the longest neurites were measured by using the ImageJ software. On the other hand expression of sAPPα was examined by western blotting. At 40 h after co-culture, CHO cells were lysed with lysis buffer (50 mM Tris-HCl, pH 7.8, 150 mM NaCl, 1% NP-40, 2 mM Na3VO4, 1 mM EDTA). The lysates and the medium of the CHO cells were centrifuged at 13,000×g for 5 min and the supernatants were collected. The supernatant of the CHO cell culture medium was collected and concentrated using centrifugal filter units (Amicon Ultra-0.5 mL 30 K MWCO, Millipore). The supernatant of the lysates and the concentrated supernatant of the medium were boiled in sample buffer for 5 min and subjected to SDS-PAGE. The proteins were transferred onto polyvinylidene difluoride (PVDF) membranes and blocked for 1 h in 5% skim milk. Membranes were blotted overnight with monoclonal anti-sAPPα antibody (3∶1000), followed by incubation with HRP-linked secondary antibody. For detection, an ECL chemiluminescence system (GE Healthcare, Little Chalfont, UK) was used.

Statistical analysis

All values are expressed as mean ± SEM. Tukey-Kramer test followed by Bonferroni/Dunn test was used in growth assay by sAPPα addition. Student's t test was applied in neurite growth assay by the co-culture method. Scheffe's F test was used in neurite growth assay followed by p75NTR neucleofecton. Kolmogrov-Smirnov test was applied for analysis of distribution of neurite length. P<0.05 was considered statistically significant.

Results

p75NTR interacts with sAPPα

To assess the possible involvement of p75NTR in the APP fragments (Figure 1A) signal transduction pathway, we first examined whether sAPPα interacted with p75NTR by a pull-down assay. His-tagged sAPPα was incubated with Ni-agarose beads to precipitate any bound protein, and then p75-Fc or IgG-Fc as a control was added. p75NTR, but not control IgG protein, was detected in sAPPα precipitates (Figure 1B). Comparable experiments using sAPPβ revealed that p75NTR protein was also detected in sAPPβ, and the C-sAPPα had precipitated p75NTR (Figure 1C and D). C-sAPPα is the carboxyl-terminal region of sAPPα, corresponding to aa 314–612 of sAPPα (aa 1–612) (Figure 1A). These results indicate that APP fragments interact with p75NTR.
Figure 1

p75NTR interacts with APP fragments.

(A) Schematic representations of APP fragments. aa: amino acids. (B–D) Pull-down assays to assess the interaction of APP fragments with p75NTR. His-tagged sAPPα (B), sAPPβ (C), and C-sAPPα (D) protein were precipitated with Ni-agarose beads. p75NTR ECD-Fc was co-precipitated with APP fragments. (E–G) Binding of recombinant APP fragments to p75NTR on p75NTR-pcDNA transfected COS-7 cells. The cells were transfected with p75NTR inserted plasmid or control plasmid, and the binding of sAPPα (E), sAPPβ (F), or C-sAPPα (G) on the cells was assessed by immunocytochemistry. Scale bar: 100 µm.

p75NTR interacts with APP fragments.

(A) Schematic representations of APP fragments. aa: amino acids. (B–D) Pull-down assays to assess the interaction of APP fragments with p75NTR. His-tagged sAPPα (B), sAPPβ (C), and C-sAPPα (D) protein were precipitated with Ni-agarose beads. p75NTR ECD-Fc was co-precipitated with APP fragments. (E–G) Binding of recombinant APP fragments to p75NTR on p75NTR-pcDNA transfected COS-7 cells. The cells were transfected with p75NTR inserted plasmid or control plasmid, and the binding of sAPPα (E), sAPPβ (F), or C-sAPPα (G) on the cells was assessed by immunocytochemistry. Scale bar: 100 µm. To examine whether APP fragments bind to p75NTR on cell surfaces, we performed cell-based binding assays. COS-7 cells were transfected with either empty control vector or HA-tagged p75NTR inserted vector. After 40 h, cells were fixed and incubated with recombinant protein of His-tagged sAPPα recombinant protein. Bound ligand was immunostained with anti-sAPPα antibody. sAPPα bound to cells expressing p75NTR but not to cells transfected with control vector (Figure 1E). We also found that sAPPβ and C-sAPPα bound to p75NTR-expressing cells (Figure 1F and G). These results suggest that APP fragments bind to p75NTR on cell surfaces.

Affinity of the sAPPα-p75NTR interaction

Next, we examined the affinity of the each APP fragments-p75NTR interactions by ELISA. The recombinant p75NTR ECD-Fc or IgG-Fc was added to plastic wells coated with one of the APP fragments (sAPPα, sAPPβ, or C-sAPPα). The binding was detected by HRP-conjugated anti-human Fc antibody. The interaction between p75NTR ECD-Fc and sAPPα was higher than that between IgG-Fc and sAPPα (Figure 2A), indicating specific binding between sAPPα and p75NTR ECD. sAPPβ and C-sAPPα also bound to p75NTR ECD-Fc (Figure 2C and E). The sigmoid dose-response formulas were used to calculate the EC50. sAPPα, sAPPβ, and C-sAPPα bound to p75NTR ECD-Fc, and EC50 were 90, 120, and 150 nM, respectively (Figure 2B, D, F). Taken together, our observations indicate that p75NTR ECD binds to APP peptides, thereby suggesting that p75NTR is the receptor for APP fragments.
Figure 2

Binding affinity of APP fragments to p75NTR.

(A, C, E) ELISA for the p75NTR-APP fragments interaction. sAPPα (A), sAPPβ (C), or C-sAPPα (E) was plated. After washing with PBS, p75NTR ECD-Fc or IgG-Fc as a control was added to the plate at the indicated concentrations. The mean OD value after adding p75NTR ECD-Fc to ELISA microwells coated with recombinant each APP peptides was higher than that of the controls. n = 3. (B, D, F) The sigmoid dose-response curve revealed the EC50 for each APP fragment-p75NTR interaction. The EC50 of sAPPα (B), sAPPβ (D), and C-sAPPα (F) to p75NTR were 90, 120, 150 nM, respectively.

Binding affinity of APP fragments to p75NTR.

(A, C, E) ELISA for the p75NTR-APP fragments interaction. sAPPα (A), sAPPβ (C), or C-sAPPα (E) was plated. After washing with PBS, p75NTR ECD-Fc or IgG-Fc as a control was added to the plate at the indicated concentrations. The mean OD value after adding p75NTR ECD-Fc to ELISA microwells coated with recombinant each APP peptides was higher than that of the controls. n = 3. (B, D, F) The sigmoid dose-response curve revealed the EC50 for each APP fragment-p75NTR interaction. The EC50 of sAPPα (B), sAPPβ (D), and C-sAPPα (F) to p75NTR were 90, 120, 150 nM, respectively.

sAPPα promotes neurite outgrowth

It has been reported that sAPPα exerts neuroprotective effects in the traumatic brain injury model [8], [11]–[13]. Therefore, we focused on cortical neurons to examine the effect of sAPPα on neurite outgrowth. For this purpose, we compared the neurite length of sAPPα-treated neurons and control ones. Cortical neurons from E16 mice were treated with IgG-Fc as control or sAPPα at concentrations of 1.22 nM, 2.44 nM, or 4.88 nM, and cultured for 24 h. Neurite outgrowth was enhanced by sAPPα treatment (Figure 3A, B, and S1A).
Figure 3

sAPPα promotes neurite outgrowth.

(A, B) Cortical neurons were cultured with IgG-Fc or sAPPα at the indicated concentrations for 24 h. (A) The representative images of cortical neurons are shown. Scale bar: 100 µm. (B) The mean lengths of the longest neurite per neuron were measured by image J software and represented in the graph. The graph showed the mean ± SEM from 3 independent experiments. The number of neurons was 150 for each experiment. * p<0.05, Tukey-Kramer test. (C) CHO cells transfected with sAPPα-inserted plasmid were immunostained with monoclonal anti-sAPPα antibody and counterstained with DAPI. (D) sAPPα expression of CHO cells was confirmed by western blotting. The supernatants of the medium and whole cell lysates were prepared from CHO cells transfected with the indicated plasmid. Scale bar: 100 µm. (E) The representative images of cortical neurons co-cultured with transfected CHO cells are shown. Scale bar: 100 µm. Left panels display immunostaining of neurites with polyclonal anti-Tuj1 antibody. Those neurons were co-cultured with CHO cells transfected with pcDNA as a control or pcDNA-sAPPα. Right panels display immunostaining of CHO cells with sAPPα. (F) Neurite outgrowth was significantly promoted when the neurons were cultured on sAPPα-expressing CHO cells compared with the culture on control CHO cells. The mean lengths of the longest neurite per neuron were measured by image J software and represented in the graph. The graph showed the mean ± SEM from 7 independent experiments. The number of neurons was 150 for each experiment. * p<0.05, Student's t-test.

sAPPα promotes neurite outgrowth.

(A, B) Cortical neurons were cultured with IgG-Fc or sAPPα at the indicated concentrations for 24 h. (A) The representative images of cortical neurons are shown. Scale bar: 100 µm. (B) The mean lengths of the longest neurite per neuron were measured by image J software and represented in the graph. The graph showed the mean ± SEM from 3 independent experiments. The number of neurons was 150 for each experiment. * p<0.05, Tukey-Kramer test. (C) CHO cells transfected with sAPPα-inserted plasmid were immunostained with monoclonal anti-sAPPα antibody and counterstained with DAPI. (D) sAPPα expression of CHO cells was confirmed by western blotting. The supernatants of the medium and whole cell lysates were prepared from CHO cells transfected with the indicated plasmid. Scale bar: 100 µm. (E) The representative images of cortical neurons co-cultured with transfected CHO cells are shown. Scale bar: 100 µm. Left panels display immunostaining of neurites with polyclonal anti-Tuj1 antibody. Those neurons were co-cultured with CHO cells transfected with pcDNA as a control or pcDNA-sAPPα. Right panels display immunostaining of CHO cells with sAPPα. (F) Neurite outgrowth was significantly promoted when the neurons were cultured on sAPPα-expressing CHO cells compared with the culture on control CHO cells. The mean lengths of the longest neurite per neuron were measured by image J software and represented in the graph. The graph showed the mean ± SEM from 7 independent experiments. The number of neurons was 150 for each experiment. * p<0.05, Student's t-test. We further examined neurite length by the co-culture method. In this method, CHO cells were transfected with either empty vector or His-tagged sAPPα inserted vector. We observed that sAPPα protein expression was only detected in sAPPα-transfected CHO cells (Figure 3C and D). Neurite outgrowth was promoted when the neurons were cultured on sAPPα-expressing CHO cells, compared to those on control CHO cells (Figure 3E, F, and S1B). These results demonstrate that sAPPα promotes neurite outgrowth in embryonic cortical neurons.

p75NTR is required for sAPPα–induced neurite outgrowth

The aforementioned results suggest that p75NTR interacted with APP fragments (Figure 1 and 2). To address whether p75NTR is a functional receptor for sAPPα, we performed a series of loss-of-function experiments using siRNA for p75NTR [24]. We first confirmed the knockdown efficacy of p75NTR siRNA in cortical neurons endogenously expressing p75NTR. Efficient downregulation of p75NTR protein was specifically observed in p75NTR siRNA-transfected cells (Figure 4A), indicating successful siRNA-mediated knockdown of p75NTR protein. We next examined whether p75NTR mediated neurite elongation by sAPPα. sAPPα promoted neurite outgrowth of E16 cortical neurons up to 18.7% of control levels. Transfection of p75NTR siRNA reversed the effect of sAPPα on neurite outgrowth to control levels (Figure 4B, C, and S1C). These results demonstrate that p75NTR mediates the promotion of neurite outgrowth by sAPPα.
Figure 4

p75NTR mediates sAPPα-induced neurite outgrowth.

(A) p75NTR siRNA specifically reduced target protein expression. Cortical neurons were transfected with scrambled control or p75NTR siRNA. Cell lysates were prepared 72 h after transfection and subjected to western blotting. β-actin expression was used as an internal control. (B, C) siRNA-mediated knockdown of endogenous p75NTR suppressed sAPPα-induced neurite outgrowth. (B) Representative images of cortical neurons are displayed. Cortical neurons were transfected with scramble siRNA (control) or p75NTR siRNA. Three days after transfection, the neurons were incubated in the presence or absence of sAPPα for 24 h. Scale bar: 100 µm. (C) The mean lengths of the longest neurite per neuron were measured by image J software and represented in the graph. The graph showed the mean ± SEM from of three independent experiments. The number of neurons was 150 for each experiment. ** p<0.01, Scheffe's F test.

p75NTR mediates sAPPα-induced neurite outgrowth.

(A) p75NTR siRNA specifically reduced target protein expression. Cortical neurons were transfected with scrambled control or p75NTR siRNA. Cell lysates were prepared 72 h after transfection and subjected to western blotting. β-actin expression was used as an internal control. (B, C) siRNA-mediated knockdown of endogenous p75NTR suppressed sAPPα-induced neurite outgrowth. (B) Representative images of cortical neurons are displayed. Cortical neurons were transfected with scramble siRNA (control) or p75NTR siRNA. Three days after transfection, the neurons were incubated in the presence or absence of sAPPα for 24 h. Scale bar: 100 µm. (C) The mean lengths of the longest neurite per neuron were measured by image J software and represented in the graph. The graph showed the mean ± SEM from of three independent experiments. The number of neurons was 150 for each experiment. ** p<0.01, Scheffe's F test.

PKA mediates sAPPα-induced neurite outgrowth

Our previous study demonstrated that neurotrophin binding to p75NTR promoted neurite outgrowth through cyclic adenosine monophosphate-protein kinase A (cAMP-PKA) [26]. We examined the hypothesis that cAMP-PKA is located downstream of p75NTR in the signaling pathway mediated by sAPPα. We confirmed that treatment of sAPPα to the culture of cortical neurons significantly enhanced neurite outgrowth in the presense of DMSO, which was used as a solvent control for PKA inhibitor KT5720. By contrast, treatment with KT5720 suppressed the effect of sAPPα on neurite outgrowth (Figure 5A, B, and S1D). These results demonstrate that PKA activation is essential for sAPPα-induced neurite outgrowth.
Figure 5

PKA is required for sAPPα-induced neurite outgrowth.

(A, B) Inhibition of PKA abolished the sAPPα-induced neurite outgrowth. Neurons were cultured with sAPPα and/or PKA inhibitor, KT5720 for 24 h. (A) The representative images of cortical neurons are shown. Scale bar: 100 µm. (B) The mean lengths of the longest neurite per neuron were measured by image J software and represented in the graph. The graph showed the means ± SEM of three independent experiments. The number of neurons was 150 for each experiment. ** p<0.01, Tukey-Kramer test.

PKA is required for sAPPα-induced neurite outgrowth.

(A, B) Inhibition of PKA abolished the sAPPα-induced neurite outgrowth. Neurons were cultured with sAPPα and/or PKA inhibitor, KT5720 for 24 h. (A) The representative images of cortical neurons are shown. Scale bar: 100 µm. (B) The mean lengths of the longest neurite per neuron were measured by image J software and represented in the graph. The graph showed the means ± SEM of three independent experiments. The number of neurons was 150 for each experiment. ** p<0.01, Tukey-Kramer test.

Discussion

In this study, we demonstrated that sAPPα binds to p75NTR and promotes neurite outgrowth. Furthermore, sAPPβ also binds to p75NTR. These results implicate p75NTR as the receptor for sAPPα in promoting neurite outgrowth. Although the effect was modest, sAPPα significantly enhanced the neurite outgrowth (Figure 3A and B). We observed that the treatment of sAPPα increased the number of cells, which had neurites longer than 180 µm (Figure S1A). These results demonstrated modest but significant effects of sAPPα on neurite elongation. In some cases, excessive neurite elongation may burden on the cells. To promote axon outgrowth, neurons undergo expansion of the plasma membrane [27]. Therefore, rapid neurite outgrowth may result in exhausting cellular biosynthesis. It is possible that sAPPα promotes neurite outgrowth with a lower stress on neurons. We calculated the EC50 of the p75NTR-APP fragments interaction with ELISA. The EC50 of sAPPα-, sAPPβ-, and C-sAPPα–p75NTR interactions were 90, 120, and 150 nM, respectively (Figure 2B, 2D and 2F). It was previously reported that the EC50 of the N-APP (APP 1–286)-p75NTR interaction is 300 nM [18]. C-sAPPα (304–612) and sAPPα (1–612) share the common region 304–612 aa (Figure 1A). C-sAPPα binds to p75NTR, whereas N-APP (1–286) also binds to p75NTR [18]. These findings indicate that sAPPα binds to p75NTR in both N- and C-terminal regions of sAPPα. That is why sAPPα bind to p75NTR with greater affinity by binding both regions. In addition, both fragments possess the region involved in the promotion of neurite outgrowth [28]–[31]. These observations suggest that both N- and C-terminal regions of sAPPα contribute to interaction with p75NTR and the regulation of neurite outgrowth. We observed that the EC50 of sAPPα-p75NTR interaction was lower than that of sAPPβ–p75NTR, indicating that, while sAPPβ also binds to p75NTR, sAPPα binds to p75NTR with greater affinity. It was reported that sAPPα is more efficient in protecting hippocampal neurons and promoting neurite outgrowth compared to sAPPβ [32], [33]. These findings suggest that the greater binding affinity of sAPPα- p75NTR might affect the neuroprotective and neurotrophic function of sAPPα. Previous study suggested that sAPPs possibly modulated NGFp75 signaling pathway [34]–[37]. In this study, we demonstrated that p75NTR knockdown blocked sAPPα-induced neurite elongation, suggesting the involvement of p75NTR in sAPPα-induced neurite outgrowth. Moreover, we revealed that sAPPα promotes neurite outgrowth through the PKA signaling pathway. p75NTR mediates neurite elongation via cAMP-PKA signaling pathway [26]. Nerve growth factor (NGF) promotes neurite outgrowth in embryonic rat hippocampal neurons and chick ciliary neurons [38]. Binding of NGF to p75NTR activates cAMP-PKA, and translocates p75NTR to lipid rafts, resulting in neurite outgrowth [26]. Therefore, it would be reasonable to implicate cAMP-PKA involvement in the downstream signaling mediated by sAPPα-p75NTR. In contrast, p75NTR also functions as a signal transducer of neurite outgrowth inhibition. When myelin-derived proteins bind to the NgR, which lacks an intracellular domain, p75NTR interacts with NgR to transduce the inhibitory signals intracellularly [39]. Next, p75NTR facilitates the release of RhoA from Rho-GDP–dissociation inhibitor (Rho-GDI), resulting in RhoA activation. The activation of RhoA has a critical role in inducing the inhibition of neurite outgrowth [40]. In this study, we showed that the PKA inhibitor KT5720 inhibited sAPPα-induced neurite outgrowth. These observations lead to our hypothesis that sAPPα also suppresses RhoA activation through p75NTR. Further studies are required to assess the validity of this hypothesis. Additionally, APP cleavage occurs during embryogenesis [3]–[5], suggesting that APP fragments are required for embryonic development. In addition, the axons of p75 mutant embryos are disturbed [41]. Based on these findings, sAPPα-p75NTR signaling may be involved in normal brain development. Furthermore, APP is expressed and cleaved dramatically in CNS injuries, such as spinal cord or traumatic brain injuries [7]–[9]. Therefore, APP cleaved products and the p75NTR signal may affect the recovery process of neural tissues. Understanding the molecular pathway may assist in the elucidation of novel therapeutic targets for CNS diseases. In conclusion, we revealed that both sAPPα and sAPPβ interact with p75NTR on COS cells. Knockdown of p75NTR suppressed the effect of sAPPα. These results support the hypothesis that p75NTR is the receptor for sAPPα in neurite outgrowth. Distribution histograms of the neurite length. (A) Cells were treated with human IgG-Fc or various doses of sAPPα for 24 h. sAPPα increased the ratio of the longer neurites. n = 3. (B) Cortical neurons were cocultured with mock or sAPPα-transfected CHO cells for 24 h. Neurons cocultured with sAPPα-transfected CHO cells increased the ratio of the longer neurites. n = 7. (C) Cortical neurons were transfected with scramble siRNA (control) or p75 siRNA. Three days after transfection, the neurons were incubated with sAPPα for 24 h. Knockdown of p75NTR reversed the effect of sAPPα on longer axons to control levels. n = 3. (D) Cortical neurons were treated with sAPPα for 24 h and/or PKA inhibitor, KT5720. Treatment with KT5720 suppressed the effect of sAPPα on neurite outgrowth. n = 3. The mean lengths of the longest neurite per neuron were measured by image J software and represented in the graph. The graph showed the mean ± SEM of independent experiments. The number of neurons was 150 for each experiment. ** p<0.01, Kolmogorov-Smirnov test. (TIF) Click here for additional data file.
  41 in total

1.  Neurotrophin binding to the p75 receptor modulates Rho activity and axonal outgrowth.

Authors:  T Yamashita; K L Tucker; Y A Barde
Journal:  Neuron       Date:  1999-11       Impact factor: 17.173

Review 2.  The neurotrophin receptor p75(NTR): novel functions and implications for diseases of the nervous system.

Authors:  Georg Dechant; Yves-Alain Barde
Journal:  Nat Neurosci       Date:  2002-11       Impact factor: 24.884

3.  Layer V cortical neurons require microglial support for survival during postnatal development.

Authors:  Masaki Ueno; Yuki Fujita; Tatsuhide Tanaka; Yuka Nakamura; Junichi Kikuta; Masaru Ishii; Toshihide Yamashita
Journal:  Nat Neurosci       Date:  2013-03-24       Impact factor: 24.884

4.  c-Jun N-terminal kinase induces axonal degeneration and limits motor recovery after spinal cord injury in mice.

Authors:  Kazuhiro Yoshimura; Masaki Ueno; Sachiko Lee; Yuka Nakamura; Akinobu Sato; Koichi Yoshimura; Haruhiko Kishima; Toshiki Yoshimine; Toshihide Yamashita
Journal:  Neurosci Res       Date:  2011-07-28       Impact factor: 3.304

5.  Characterization of the neurotrophic interaction between nerve growth factor and secreted alpha-amyloid precursor protein.

Authors:  J J Luo; M S Wallace; D B Hawver; J W Kusiak; W C Wallace
Journal:  J Neurosci Res       Date:  2001-03-01       Impact factor: 4.164

6.  Beta-amyloid induces neuronal apoptosis via a mechanism that involves the c-Jun N-terminal kinase pathway and the induction of Fas ligand.

Authors:  Y Morishima; Y Gotoh; J Zieg; T Barrett; H Takano; R Flavell; R J Davis; Y Shirasaki; M E Greenberg
Journal:  J Neurosci       Date:  2001-10-01       Impact factor: 6.167

7.  P75 interacts with the Nogo receptor as a co-receptor for Nogo, MAG and OMgp.

Authors:  Kevin C Wang; Jieun A Kim; Rajeev Sivasankaran; Rosalind Segal; Zhigang He
Journal:  Nature       Date:  2002-10-20       Impact factor: 49.962

Review 8.  Neurotrophin signal transduction in the nervous system.

Authors:  D R Kaplan; F D Miller
Journal:  Curr Opin Neurobiol       Date:  2000-06       Impact factor: 6.627

9.  Minocycline restores sAPPα levels and reduces the late histopathological consequences of traumatic brain injury in mice.

Authors:  Eleni Siopi; Angelo H Cho; Shadi Homsi; Nicole Croci; Michel Plotkine; Catherine Marchand-Leroux; Mehrnaz Jafarian-Tehrani
Journal:  J Neurotrauma       Date:  2011-09-23       Impact factor: 5.269

10.  The p75 receptor transduces the signal from myelin-associated glycoprotein to Rho.

Authors:  Toshihide Yamashita; Haruhisa Higuchi; Masaya Tohyama
Journal:  J Cell Biol       Date:  2002-05-13       Impact factor: 10.539

View more
  20 in total

1.  Amyloid precursor protein in pancreatic islets.

Authors:  Joshua A Kulas; Kendra L Puig; Colin K Combs
Journal:  J Endocrinol       Date:  2017-07-14       Impact factor: 4.286

Review 2.  Cellular Trafficking of Amyloid Precursor Protein in Amyloidogenesis Physiological and Pathological Significance.

Authors:  Noralyn Basco Mañucat-Tan; Khalil Saadipour; Yan-Jiang Wang; Larisa Bobrovskaya; Xin-Fu Zhou
Journal:  Mol Neurobiol       Date:  2018-05-24       Impact factor: 5.590

Review 3.  The Ubiquitin-Proteasome System and Molecular Chaperone Deregulation in Alzheimer's Disease.

Authors:  Yanuar Alan Sulistio; Klaus Heese
Journal:  Mol Neurobiol       Date:  2015-01-07       Impact factor: 5.590

Review 4.  Filling the void: a role for exercise-induced BDNF and brain amyloid precursor protein processing.

Authors:  Rebecca E K MacPherson
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2017-08-16       Impact factor: 3.619

Review 5.  Restoring Soluble Amyloid Precursor Protein α Functions as a Potential Treatment for Alzheimer's Disease.

Authors:  Ahsan Habib; Darrell Sawmiller; Jun Tan
Journal:  J Neurosci Res       Date:  2016-08-17       Impact factor: 4.164

6.  Apolipoprotein E-mediated Modulation of ADAM10 in Alzheimer's Disease.

Authors:  Ben Shackleton; Fiona Crawford; Corbin Bachmeier
Journal:  Curr Alzheimer Res       Date:  2017       Impact factor: 3.498

7.  Soluble Amyloid Precursor Protein Alpha Interacts with alpha3-Na, K-ATPAse to Induce Axonal Outgrowth but Not Neuroprotection: Evidence for Distinct Mechanisms Underlying these Properties.

Authors:  Emilie Dorard; Stéphanie Chasseigneaux; Lucie Gorisse-Hussonnois; Cédric Broussard; Thierry Pillot; Bernadette Allinquant
Journal:  Mol Neurobiol       Date:  2017-10-05       Impact factor: 5.590

Review 8.  Neuroketotherapeutics: A modern review of a century-old therapy.

Authors:  Scott J Koppel; Russell H Swerdlow
Journal:  Neurochem Int       Date:  2017-06-01       Impact factor: 3.921

Review 9.  APP Receptor? To Be or Not To Be.

Authors:  Carole Deyts; Gopal Thinakaran; Angèle T Parent
Journal:  Trends Pharmacol Sci       Date:  2016-01-31       Impact factor: 14.819

10.  Oral Administration of Gintonin Attenuates Cholinergic Impairments by Scopolamine, Amyloid-β Protein, and Mouse Model of Alzheimer's Disease.

Authors:  Hyeon-Joong Kim; Eun-Joo Shin; Byung-Hwan Lee; Sun-Hye Choi; Seok-Won Jung; Ik-Hyun Cho; Sung-Hee Hwang; Joon Yong Kim; Jung-Soo Han; ChiHye Chung; Choon-Gon Jang; Hyewon Rhim; Hyoung-Chun Kim; Seung-Yeol Nah
Journal:  Mol Cells       Date:  2015-08-07       Impact factor: 5.034

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.